I just can't seem to find a researcher interested. Have tried before.
The problem is that it isn't this simple. It's not a matter of CCC with neuro-immune disease and everyone else without neuro-imune disease. Using Fukuda properly, we do find neuro-immune disease, and in a larger percentage than would be expected from only the CCC patients included in Fukuda. Dr. Nancy Klimas' NK cell profile for biological markers is, I think, developed in Fukuda-CFS. Fukuda-CFS and CCC-CFS do seem to be related (even though Fukuda-CFS lets other diseases slip in as well, even when used properly). Whether that's becasue they are the same, or just that they are similar, requires actual well-funded research and more biomarkers.
But with Fukuda, neuro-immune disease should be an EXCLUSION. Reading Fukuda- it's very much 'diagnosis of exclusion' as a synonym for 'medically unexplained'. If Fukuda are finding neuro-immune disease, it's because doctors are NOT- technically - using them 'correctly', ironically! Canada advise excluding certain conditions, but as a 'clinical' diagnosis process. Jason's RESEARCH criteria using the CC are not looking for 'diagnosis of exclusion' as such. At the very least they should be used to identify cohorts for further study, which is currently what we do not have.
BTW, Oxford-"CFS" have biomarkers, too, just not ones that doctors typically check. MDD and bipolar disease, for example, have mitochondrial dysfunction (less severe than ours, but very real). Vitamin D deficiency can be found if you actually check. And so forth. All of these diseases are real and most of them are biomedical, it's just that it's stupid and unscientific to throw a bunch of uninvestigated (or under-investigated) fatigue cases together and call it a disease. It even worse to call this group by the name of a different, established disease. That's outright fraudulent
Actually - if you look at Wessely and Cleare's explanation of their cohort for the Erlwein et al negative XMRV atudy on PlosOne, and go and look at the papers they quote, it becomes very interesting. Wessely et al's RESEARCH cohorts DO appear to be screened thoroughly to EXCLUDE disease markers. Biomedical disease may slip under the net- but the PURPOSE of Oxford IS to find a chronic fatigue research cohort - so if it is happening (biomedical disease under the net), it's happening extremely rarely by the looks of it.
I've been having a think, and I think that, right now, the most important thing our entire community needs to be pushing for is for a separation of ME from other fatiguing illnesses. I think that all of our patient organisations need to come together to organise a big, single, concerted campaign to fight for the Canadian definitions, or better, to be used, so that ME can be treated as a single, distinct, disease in its own right. I think this would immediately make so much difference to our lives, especially in terms of stigma, and understanding of the disease.
I don't understand why all the separate ME charities and patient organisations haven't come together to do this already. They've had 30 years or so to get organised!
Do many of you share these thoughts at all?
But with Fukuda, neuro-immune disease should be an EXCLUSION. Reading Fukuda- it's very much 'diagnosis of exclusion' as a synonym for 'medically unexplained'. If Fukuda are finding neuro-immune disease, it's because doctors are NOT- technically - using them 'correctly', ironically! Canada advise excluding certain conditions, but as a 'clinical' diagnosis process. Jason's RESEARCH criteria using the CC are not looking for 'diagnosis of exclusion' as such. At the very least they should be used to identify cohorts for further study, which is currently what we do not have.
Diagnosis of the chronic fatigue syndrome can be made only after alternative medical and psychiatric causes of chronic fatiguing illness have been excluded.
Several general points must be appreciated if these guidelines are to be used as intended. First, the overall purpose of the proposed conceptual framework and guidelines is to foster a more systematic and comprehensive approach toward the collection of data about the chronic fatigue syndrome and similar illnesses. As such, these tools are intended for use as standard references. However, none of the components, including the revised case definition of the chronic fatigue syndrome, can be considered definitive. These research tools will evolve as new knowledge is gained.
Second, none of the provisions in these guidelines, especially the definition of idiopathic chronic fatigue and subgroups of the chronic fatigue syndrome, establish new clinical entities. Rather, these definitions were designed to facilitate comparative studies.
Finally, general reference to these guidelines should not be substituted for clear and detailed methodologic descriptions when reporting studies. The lack of detailed information about the sources, selection, and evaluation of study participants (including controls), case definitions, and measurement techniques in reports of chronic fatigue syndrome research has contributed substantially to our current difficulties in interpreting research findings.
Several specific points about the clinical evaluation are worth emphasizing. The primary purpose of clinically evaluating a person with unexplained fatigue is to identify and treat any underlying and contributing factors. Such an evaluation should begin, whenever possible, before 6 months have elapsed. Because the particulars of any clinical evaluation will vary from patient to patient our recommendations have been limited to those aspects of clinical evaluation that can be universally applied to all patients.
Actually - if you look at Wessely and Cleare's explanation of their cohort for the Erlwein et al negative XMRV atudy on PlosOne, and go and look at the papers they quote, it becomes very interesting. Wessely et al's RESEARCH cohorts DO appear to be screened thoroughly to EXCLUDE disease markers. Biomedical disease may slip under the net- but the PURPOSE of Oxford IS to find a chronic fatigue research cohort - so if it is happening (biomedical disease under the net), it's happening extremely rarely by the looks of it.
This is the purpose of Oxford, and doubtless some choose to use Fukuda in this manner as well, and no doubt some of the actual authors of Fukuda preferred to do this. However, as it was written and published, this is an incorrect use of Fukuda. The correct use of Fukuda is to exclude other causes, and to eventually find a better way to diagnose CFS with actual diagnostic tests, since they incorrectly rejected the idea that they were looking at cases of ME.
Fukuda et al. state (emphasis mine):
Of course, they made a lot of mistakes in Fukuda and it's a problematic criteria. But it's not meant to remain a medically unexplained disease. The fact that CDC continues to say the exact same things that Fukuda said is telling about how resistant to information they continue to be.
The Wessely school research cohorts are, yes. For standard clinical diseases. If you know what to check (and only then), you do find biomarkers in MDD and similar diseases (which is what a lot of these research cohorts have), but these are not the types of things they checked for. These are new developments in research and not something that would be a clinical standard. Also the research cohorts would miss rare diseases, and early cases and rare forms of standard diseases.
The clinical diagnosis Wessely school cohorts, on the other hand, are not well checked for anything, and if they are checked, are checked only for the most obvious expected diseases.
...the authors express some resentment towards those legitimately have
questioned this research cohort and the criteria over the years, which is rather
surprising. Contrary to the insinuation by the authors, no person on the Plosone
responses forum has insinuated that the research cohort they use are somehow
'less deserving' than say, the WPI cohort, purely that they are a different type
of patient, using different criteria that select a different population, and
that this may cause problems with the findings, and claims made based on those
findings, with regard to the British 'CFS' population. This is a reasonable
concern to express, and such a deduction can be made based on the evidence the
authors provide themselves in their paper, citations, and their response. For
example, their paper states:
"Patients in our CFS cohort had undergone medical screening to exclude
detectable organic illness".
In the authors' response here, they also write:
"Thus patients in our service have also co operated in studies of PET and fMRI
neuroimaging, autonomic dysfunction, neurochemistry, respiratory function,
vitamin status, anti nuclear antibodies, immune function, neuroendocrine
function and genetics "
While patients being processed for a research cohort may well, indeed are
likely, to have co-operated and had such tests done, this does not necessarily
mean that patients with positive results are part of the research cohort.
Indeed, positive results, which would indicate organic abnormality, would surely
be likely to prevent a patient being selected for a cohort, by the very logic
described in the author's paper here, by their own response (the additional
tests are considered `not clinically necessary'?) and in at least one of their
citations (Quarmby et al)? In the Quarmby et al paper, the cohort is described,
in which the criteria used (in addition to 'Fukuda/CDC') is 'Oxford'. The Oxford
criteria (Sharpe et al 1991) in particular actually do allow for patients who
fulfil organic abnormality to be selected out of a research cohort. Indeed,
Anthony David, referring to these, commented at the time:
"British Investigators have put forward an alternative, less strict, operational
definition which is essentially chronic (6 months or more) severe disabling
fatigue in the absence of neurological signs with myalgia, psychiatric symptoms
and previous viral infections as common associated features."Here special attention needs to be paid to the term `previous viral infections'
and `absence of neurological signs', in order to contextualise the cohort
selection process applied using the Oxford Criteria.
It is therefore quite reasonable to presume that patients in the cohort
described in the Erlwein et al paper are less likely to be suffering from
organic abnormalities associated with 'CFS' populations than in other research
cohorts. It is also rational to be concerned that the cohort described here may
not be representative of many people diagnosed with 'CFS' in Britain. NICE
guidelines for example, acknowledge that very little research has been done on
`severely affected' patients, who comprise, possibly at least 25% of the
population of people given a `CFS' diagnosis (though so little research has been
done on `severely affected` in Britain, the true number is not yet clear). While
patients potentially destined for a research cohort which weeds out `detectable
organic abnormality' may be subjected to a rigorous amount of investigations,
those not undergoing this process do not undergo such testing, at least not in
the NHS. Indeed, such investigations of clinical patients are severely
proscribed in the majority of `guidelines': NICE, and the RCPCH guidelines as
just two examples. Ironically, Fukuda guidelines also make the following
comment:
"The use of tests to diagnose the chronic fatigue syndrome should be done only
in the setting of protocol-based research.
In clinical practice, no additional tests, including laboratory tests and
neuro-imaging studies, can be recommended. Examples of specific tests (which
should not be done) include serologic tests for enteroviruses; tests of
immunologic function, and imaging studies, including magnetic resonance imaging
scans and radionuclide scans (such as single photon emission computed
tomography
(SPECT) and positron emission tomography (PET) of the head.
We consider a mental status examination to be the minimal acceptable level of
assessment." (1994That clinical populations are not to be afforded the types of investigations
given to research populations makes the whole idea of `medically unexplained' or
`unexplained by disease', or 'functional' (as synonymous with 'non-organic' or
not discernibly organic`) as common characterisations of CFS (including by at
least one of the authors themselves in previous publications, for just one
example, Page et al, 2003) highly problematic at best.
It is also significant that `CFS' is so often described as a `diagnosis of
exclusion' (see, for example, the Centre for Disease Control CFS information
website (Footnote: http://www.cdc.gov/cfs/cfsdiagnosis.htm) . Certain research
case definitions comply with this assumption, such as the Oxford Criteria
(Sharpe et al, 1991) and CDC Criteria (Fukuda et al, 1994) Here, `diagnosis of
exclusion' also functions as a euphemism of `medically unexplained'. The key
problem within this recurring theme in the literature, which most frequently
remains un-addressed, is how a clinical patient's condition can all too easily
become `medically unexplained' because of the practice of encouraging doctors to
severely limit investigations in the first place: except, it would appear,
ironically, in research populations in which `organic' illness is being weeded
out to provide the type of cohort that might fulfil `not organically ill'
definitions.
The issue of `disability' also needs to be clarified. The references cited in
the Erlwein paper to support the statement that the patient cohort was of 'high
levels of disability' refer only to 'disability' in psycho-social terms or
feelings of `fatigue`, and not in terms of physical impairment, a key omission.
Mundt et al's paper in particular focuses on specific mental health problems and
the social exclusionary effects of living with these. While in no way
invalidating or trivialising the disability caused by mental health problems, it
must be pointed out that both Mundt et al and Chalder Scales nevertheless fail
to elucidate a high level of physical or physiological (say, for example,
neurological, mitochondrial and/or cardiovascular) impairment, key problems
present in people given a clinical diagnosis of `CFS', usually related to
specific organic abnormalities that can be found, if they are tested for in the
first place.
With regard to the Canadian criteria (Carruthers et al), in fact they have
undergone some `validation'. Jason et al found:
"…Canadian criteria selecting cases with less psychiatric co-morbidity, more
physical functional impairment, and more fatigue/weakness, neuropsychiatric, and
neurologic symptoms. The overall findings suggest that the Canadian clinical
criteria appear to select a more symptomatic group of individuals than the CFS
criteria, and these individuals do demonstrate less current and lifetime
psychiatric impairment than those selected according to the CFS criteria. In
contrast, the CFS group was not significantly different from the Chronic
fatigue-psychiatric group in psychiatric impairment. Predictably, the Chronic
fatigue-psychiatric group evidenced the highest frequency of current and
lifetime psychiatric disorders… Overall, there were 17 significant symptom
differences between the Canadian and Chronic fatigue-psychiatric group, but only
7 significant symptom differences between the CFS and Chronic
fatigue-psychiatric group. Findings suggest that the Canadian criteria select a
group of patients with more symptoms, and the Canadian criteria identify a group
with higher levels of physical functional impairment and less psychiatric
comorbidity. Findings from the present study indicate that the Canadian criteria
does capture many of these cardiopulmonary and neurological abnormalities, which
are not currently assessed by the current CFS case definition (Fukuda et al.,
1994). However, it is worth noting that when the Fukuda et al. (1994) CFS case
definition was conceived, the research had not yet been done investigating these
abnormalities. In combination with symptom patterns, it is possible to conclude
that the Canadian group does select individuals with greater impairment,
particularly given the physical composite score, fatigue/weakness, neurologic
and neuropsychiatric symptoms, as these symptoms can interfere with daily living
and occupational performance. Results from this present investigation highlight
the importance of contrasting different diagnostic criteria in order to gain a
greater understanding of the syndrome now known as CFS. The findings do suggest
that the Canadian criteria point to the potential utility in designating
post-exertional malaise and fatigue, sleep dysfunction, pain, clinical
neurocognitive, and clinical autonomic/ neuroimmunoendocrine symptoms as major
criteria for future attempts to define this syndrome..."
(http://www.mefmaction.net/Patients/Articles/Diagnosis/ComparingDefinitionsJL/ta\
bid/223/Default.aspx)
In addition to using the Carruthers et al criteria (or `Canadian Criteria`), the
WPI give this information about their patient cohort in their supporting online
material:
"Their diagnosis of CFS is based upon prolonged disabling fatigue and the
presence of cognitive deficits and reproducible immunological abnormalities.
These included but were not limited to peturbations of the 2-5A synthetase/RNase
L antiviral pathway, low natural killer cell cytotoxicity (as measured by
standard diagnostic assyas) and elevated cytokines particularly interleukin-6
and interleukin-8. In addition to these immunological abnormalities, the
patients characteristically demonstrated impaired exercise performance with
extremely low VO2 max measured on stress testing..."
(www.sciencemag.org/cgi/content/full/117905/DC1)
It is therefore highly unlikely, as the authors indeed acknowledge in their
reply here, that Erlwein et al were testing the same type of patient as those
tested by the WPI, which inevitably makes the Erlwein et al findings- and
perhaps some of the wilder claims that they have `cast serious doubt' on the
WPI`s findings, unfortunately made in some of the lay media- not scientifically
tenable. The failure of Erlwein et al to include such type of patient in their
cohort, however. does not mean that such patients do not exist in Britain.
Copious patient anecdotal experience, research reports, and charity surveys
indicate that they do exist. Whether XMRV is present or not is another matter,
but there are enough identifiable problems around patient selection alone with
the Erlwein et al paper to indicate this is not a definitive disproving of the
existence of the virus in Britain.
Ongoing neglect of the importance of establishing a possible `CFS' patient
population in Britain, clinically and in research settings, using the Canadian
Guidelines, is preventing the development of knowledge that might help extremely
ill and disabled people here in Britain.
The problems I have briefly outlined here do not fully express the range and
depths of problems with regard to: the identity of an accurate `CFS' population;
the instabilities of `CFS' criteria per se; the faulty concepts of `medically
unexplained' or `functional` and relation to `psychogenic` explanations for
somatic illness; the vagaries of criteria that claim to facilitate a `diagnosis
of exclusion'; and the psychogenic dismissal of serious organic dysfunction of
patients given a 'CFS' diagnosis, problems that have happened for many years.
These problems are relevant to the Erlwein et al paper. Furthermore, they are
highly relevant to all research that claim a psychological and/or behavioural
aetiology to the condition or conditions that get deemed as `CFS'.
REFERENCES
Carruthers, B. et al (2003) "Myalgic Encephalomyelitis/Chronic Fatigue Syndrome:
Clinical Working Case Definition, Diagnostic and Treatment Protocols" Journal of
Chronic Fatigue Syndrome, Vol. 11(1), pp 7 - 115.
Chalder, T. Berelowitz, G. Pawlikowska, T. Watts, L. Wessely, S. Wright, D.
Wallace, E. P. 'Development of a fatigue scale' Journal of Psychosomatic
Research Vol 37: Issue 2: Feb 1993: 147-153.
David, A.S. `Postviral syndrome and psychiatry` British Medical Bulletin: 1991:
47: 4: 966-988
Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A. 'The chronic
fatigue syndrome: a comprehensive approach to its definition and study' Ann
Intern Med. 1994 Dec 15;121(12):953-9.
Jason LA, Torres-Harding SR, Jurgens A, Helgerson J. "Comparing the Fukuda et
al. Criteria and the Canadian Case Definition for chronic Fatigue Syndrome".
Journal of Chronic Fatigue Syndrome 12(1):37-52, 2004
Mundt, J.C. Marks, I.MShear, K. Griest, J.H. 'The work and social adjustment
scale: a simple measurement of impairment in functioning' British Journal of
Psychiatry (2002) 180: 461-443
Page, L.A. Wessely, S. 'Medically unexplained symptoms: exacerbating factors in
the doctor–patient encounter' J R Soc Med 2003;96:223-227
Sharpe MC, Archard LC, Banatvala JE, Borysiewicz LK, Clare AW, David A, Edwards
RH, Hawton KE, Lambert HP, Lane RJ, et al ' Chronic fatigue syndrome: guidelines
for research' J R Soc Med. 1991 Feb;84(2):118-21.
Hi Dolphin, the original Drs who did the research that found measurable CNS damage in M.E patients using SPECT scans where Drs Jay Goldstein and Isamael Mena during the 1980s, it’s online somewhere sorry to tired to search for it at the moment. Since the invention of CFS however almost all work on this subject has stopped.
However there has been one study going on for decades involving thousands of patients and this is the work of Dr Byron Hyde who uses SPECT scans on all his patients and he has consistently found this damage to the CNS only in patients with M.E and not in patients with CFS, he then intensively investigates the CFS patients and finds that up to 80% have been misdiagnosed and are suffering from other known diseases, he blames his failure to find the cause in the remaining 20% on his own limitations as a physician, not on them having some mysterious new disease.
If you want to read more on this subject a lot of articles by Dr Hyde and other doctors like Dowsett who know the difference between M.E and CFS and a lot of information on the invention of CFS, misdiagnosis etc, etc can be found here http://www.hfme.org/
All the best
I think if I were sitting down with a blank sheet of paper, and defining my own campaigning strategy, what I would be saying is: get a big research project together, collect masses of data about the patients in this wastebasket, and then do cluster analysis to scientifically identify the subgroups. I'm starting to think once again that maybe that really is the only correct approach to take, scientifically.
Hi Mark, what Im saying is that the introduction of SPECT scans for M.E would mean that you would be able to very quickly diagnose who has M.E and who doesnt and if the CFS disease Category was abandoned doctors wouldnt be able to just dump the rest of the people who didnt fail the SPECT scan in this category and instead would be forced to investigate them properly and find out which of the numerous diseases that get misdiagnosed as M.E they actually had. The beauty of using SPECT scans is that there is 100% proof of weather the patient does or does not have M.E. Yes it is a shame that more work has not been published on SPECT scans and M.E but the M.E community should be advocating that it gets done!
Of course there will be people who have been diagnosed using the CCC who will be proved to not have M.E the reason being that it is an inaccurate criteria written by people who do not understand that M.E and CFS are different things. Which is why Im proposing that the nightingale definition should be used instead.
Probably the biggest mistake that is leading to so much confusion is the belief that PEM is exclusive to M.E, there is no truth in this whatsoever PEM, the same as Fatigue is found in numerous conditions and using PEM as proof that someone has M.E can only lead to people being misdiagnosed as I was.
I'm unclear: are you saying you are somebody who was diagnosed with ME and fits the CCC but eventually discovered that your correct diagnosis is hemochromatosis? I think that's what you're saying, but not exactly sure I got it right...I have PEM and I have hemochromatosis, in fact I have almost every symptom named in the CCC.
I'm not sure that's the same thing. PEM to me is: feeling relatively OK, somewhat recovered, then attempting to exercise, and finding that however long one rests for, and however much the other symptoms stabilise, as soon as one begins to exercise again the symptoms return. So not the same as exercising when in a bedbound state. But admittedly it's the same as exercising when one's sick...If you think about it logically if you went to a hospital ward that was filled with people with a assortment of chronic illness and then put them through physical and mental exertion does anybody actually believe that these people wouldnt then experience post exertion malaise and or pain? PEM is one of the reasons why doctors prescribe bed rest for sick patients its that common!
I quite agree. CFS is in practice a diagnosis that excludes one from further medical tests - I think that for many doctors it is in practice a way of saying "I have run out of money (and patience) to spend on figuring out what's wrong with you: I give up."Going on to the subject of why CFS should be abandoned as a disease category. As everybody knows CFS is a disease of exclusion and all the criteria have incomplete lists of diseases that should be excluded, but we all know the reality is that this doesnt happen! And most people only get a small amount of testing done before they get diagnosed with CFS and once diagnosed with CFS it becomes very hard to get more testing done, because of the belief that people with CFS dont fail test so therefore it is a waste of money.
I can't even begin to disagree with that either: I have heard about loads of possible medical conditions I might have on here, that I have not been tested for, and the concept of a "diagnosis of exclusion" is fundamentally illogical, so yes: I agree. And there definitely will be many people under this diagnosis of CFS who have medically-understood conditions that haven't been correctly diagnosed.Where it gets really interesting is when you realise just how incomplete these exclusion lists are! It may shock a lot of people to know that the number of medical conditions that can cause chronic fatigue is 297 link here http://en.diagnosispro.com/differen...ific-agent-chronic-fatigue/25271-154-170.html Now I think we can take it as read that no patient on the planet has ever managed to convince their doctors to run tests for all these conditions and there has never been a study done by the medical community where they have run test for all these conditions on someone diagnosed with CFS. So therefore there has never, ever been anyone who has had all the tests for all the conditions that causes chronic fatigue. Which means there has never been anybody who has had every possibility excluded. The only Logical and Scientific conclusion that anyone can come to, is that there is no evidence what so ever that CFS exists!
I agree that the closer you get to the psych lobby interpretations, the closer you get to them saying that CFS is now supposed to be a definition of "psychosomatic" and if you have anything provably wrong with you medically, you can't have CFS by definition. That's a twisted definition of things though, in order to create an illogical category that just means "can't find the problem" - something more like CCC, or even Fukuda used well, isn't intended to be used as meaning "no failed tests, no neurological symptoms", and good CFS physicians are reporting finding patterns amongst their patients that don't fit any known medical conditions.The other interesting thing about CFS is it is supposed to be medically unexplained which means nobody diagnosed with it can have any failed blood tests, if they do have a failed blood test its no longer medically unexplained, there problem is caused by one of the conditions that causes, say low iron.
Are you kidding me??!! Do I come across as somebody who is short of work to do?...I see your a moderator Mark and have noticed that there is working being done collating a lot of information by this web site, I recommend that you do this. Go through the posts on this forum and write down all the failed tests that people here have.
Yes, there are a lot of people who report failing tests. I myself have many failed tests regarding sensitivities, abnormal vitamin levels etc...but none of them are accepted or agreed with by the medical authorities here, although given my experience I am 100% confident that they accurately describe aspects of my physical illness. But I'm not sure what that's supposed to imply, that many people report failed tests but nobody seems to know what that means...I don't see how it implies that those people can't have ME or can't have CFS...people with ME/CFS can have other things wrong too...A couple of hours going through laboratory testing section will reveal why this is important, there are people mentioning there failed tests in a lot of the other sections as well.
Well I don't see anything strange there, but I never did accept the premise that to have CFS you can't have failed any medical tests - that seems to be a psych lobby construction in order to define CFS as non-physical.What you will soon find is the most staggering array of failed tests imaginable, which is somewhat strange for an illness where people dont fail tests!
Again: doing that work of writing all those symptoms down is not going to happen I'm afraid! But on the plus side, I'm heavily involved in working on a project that will do essentially what you describe in vastly more detail...coming soon...and if you're right in what you say, this project should confirm it.If at the same time you also write down all the different symptoms that people here have, you will soon find that to qualify for a diagnosis of CFS you can fail almost every diagnostic test under the sun and have almost any symptom you want!
Once again I find myself half-agreeing. I think there is probably a lot of what you describe: undiagnosed conditions and lazy doctors. At the same time, the problems don't seem to be easy to solve, to find that right diagnosis.The only logical conclusion that anyone can come to when they gather this information is that this is not a CFS forum, it is a forum full of misdiagnosed people who the only thing they have in common is that their doctors are lazy and incompetent and cant be bothered either looking up on the internet what these failed tests and symptoms mean or looking them up in the medical text books they have in their office.
Good point.The other baffling thing about CFS is that it happened in reverse to the process that every other disease on the planet has. By this I mean that every other disease has got it name because groups of people where found, who had a disease that was not the same as the other known illnesses and they were then studied and the illness was named.
Don't know much about the history of ME and how it was understood/treated before 1988, but that period was a watershed for sure and something went horribly wrong around that time which has obscured all the issues ever since. So I don't know whether what you say is true, but it sounds quite extraordinary if ME really was that well-understood before 1988.CFS happened in reverse! Before 1988 there was no mystery about M.E and hadnt been since the 1930s epidemics, it was well known that it was a disease with a short incubation period that caused measurable damage to the central nervous system which had been seen in autopsy, they had even inject blood from M.E suffers into monkeys and they had developed the same illness and one had died. There was still debate about the cause, but there was a lot of evidence that it was caused by members of the entro virus family. There were people with chronic Epstein Barr but theres no mystery about that, they had chronic EBV. There simply werent millions of people with unexplained fatigue waiting round for someone to put a name on it!
Well really I think that at least part of the reason why the definition got broadened in this way and millions of people turned up with CFS, is because the invention of CFS was at least partly a response to the fact that these types of illness are growing, rapidly, and were growing in prevalence prior to 1988, and indeed they are continuing to grow in prevalence. That's also true of autism, Multiple Sclerosis, immune disorders in general, and a whole host of other medical problems - they have all been growing in prevalence and particularly so since the 80s, and the graphs (if read carefully) all seem to follow the same curve. I take that as evidence of a spreading infection, an epidemic or indeed pandemic spread over decades, and it's part of the reason why XMRV makes so much sense to me as a theory that underlies all these conditions that are rising, as a long-term epidemic of a retrovirus that can provoke a variety of conditions.Then the CDC invented Chronic Fatigue Syndrome and then all of a sudden millions of people suddenly started developing this illness! How odd! Are the members of the CDC who invented this disease psychic? Or is it just a strange coincidence that CFS gives doctors an excuse for not investigating patient who present with fatigue properly as they always had to in the past!
Not at all, you're not ruffling my feathers and I hope not anybody else's.Sorry if yet again Im raffling a few feathers by pointing these facts out, but if this mess is every going to end then the truth needs to be told, M.E is a very real but rare diseases, CFS is not a disease its a misdiagnosis, PEM is a common feature of a lot of illnesses, the CCC is not a good criteria for diagnosing M.E the nightingale definition is, a lot of people on this forum are misdiagnosed and their doctors are blatantly incompetent.
It is by accepting facts like these that I stopped believing in CFS and instead did everything I could to find out what was really causing my illness, its taken a long time and I have had to sack a lot of doctors and learn vast amounts of information on numerous diseases, but I got there in the end and as long as I dont have permanent organ damage due to delayed diagnosis I will be able to get my life back.
We don't: I'm not waiting, I'm working on it myselfI think this is how medicine in general will be done in the future. But how long do we have to wait?